UNH - Novo blames pharma middlemen over Wegovy pricing: Bloomberg News
2024-05-28 12:02:07 ET
More on Novo Nordisk
- Novo Nordisk: The Market Is Right, Don't Fight Against It
- Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study
- Novo Nordisk: Considerable Growth Beyond Ozempic
- SA Asks: Who will launch the next big weight-loss drug?
- Novo Nordisk’s Wegovy improves kidney health in addition to weight loss: study